Seeking Alpha

Sarepta Therapeutics beats by $0.17, misses on revenues

  • Sarepta Therapeutics (SRPT): Q2 EPS of -$0.46 beats by $0.17.
  • Revenue of $3.0M misses by $2.08M. (PR)

Check out Seeking Alpha’s new Earnings Center »

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs